Etoposide is marketed under several trade names, with Vumon being a prominent one [1][2]. It is also known by the brand names Etopophos and Lastet [2].
What is Etoposide used for?
Etoposide is a chemotherapy drug used to treat various types of cancer. It is particularly effective against certain solid tumors and hematological malignancies [3][4]. Its applications include treating lung cancer (both small cell and non-small cell), testicular cancer, lymphoma, and leukemia [3][4].
How does Etoposide work?
Etoposide is a topoisomerase inhibitor [4]. It works by interfering with an enzyme called topoisomerase II, which is essential for DNA replication and repair in rapidly dividing cancer cells [4][5]. By inhibiting this enzyme, etoposide causes breaks in the DNA strands, ultimately leading to the death of cancer cells [4][5].
When does the patent for Etoposide expire?
As etoposide is an older drug, its original patents have long since expired, allowing for the availability of generic versions. However, specific formulations or delivery methods might have newer patents. For detailed information on patent expiry dates for specific etoposide products or formulations, resources like DrugPatentWatch.com can be consulted [6].
Who manufactures Etoposide?
Etoposide is manufactured by various pharmaceutical companies. For example, Vumon was historically associated with Bristol-Myers Squibb [1]. Generic versions are produced by numerous companies worldwide, reflecting its status as an established chemotherapy agent [2].
What are the alternatives to Etoposide?
The choice of cancer treatment depends on the specific type and stage of cancer, as well as the patient's overall health. Alternative chemotherapy drugs used for similar cancers include cisplatin, carboplatin, paclitaxel, and vincristine [3]. In some cases, radiation therapy, surgery, or immunotherapy may also be used as standalone treatments or in combination with chemotherapy [3].